Samyang Holdings's Croquis® Shows New Clinical Cases of PDO thread lift at AMWC 2024
* Sharing Clinical Cases of "Croquis® at AMWC 2024 in Monaco. * Expand market with proven safety and efficacy, 29 countries worldwide. * "Croquis®" Lifting Threads with Samyang' 25 years Expertise in Global Biodegradable Suture Threads. SEOUL, South Korea, April 3, 2024 /PRNewswire/ -- Samy...
KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide
* Evaluated firstly as a L'Oreal partner in 2013 and achieved the highest rating in 11 years * Efforts to establish an ESG committee, reinforce labor and human rights management, and improve management of partners SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Samyang Group announced that ...
Samyang Holdings Presents Clinical Cases of 'Lafullen® and Croquis®' at KOAT Academic Conference
* Presentation of "Lafullen®" and "Croquis®" Procedures and Clinical Cases... Confirming Product Excellence and Safety * Biodegradable Polymer Filler "Lafullen®" Maintains Natural Volume for 2 Years * "Croquis®" Lifting Threads with Samyang' expertise in Global Biodegradable Suture Threa...
Samyang Signs Partnership Agreement with Yxintent, China for Dermal Filler Lafullen®
* Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval inChina, with Samyang supplying products worth KRW 100 billion over the next five years * Long-lasting biodegradable dermal filler with natural volume and long-lasting effects, proven safety and efficacy ...
KCI, a subsidiary of Samyang Group, has been awarded a 'Gold Medal' in EcoVadis' ESG Rating, placing the company in the top 5% worldwide.
SEOUL, South Korea, May 23, 2023 /PRNewswire/ -- KCI Ltd., a subsidiary of Samyang Group specializing in cosmetics and personal care materials, has been awarded 'Gold Medal' status in the 2023 Sustainability Rating from 'EcoVadis,' the world's largest ESG rating organization. This prestigious rec...
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics
* Implementation of Samyang Holdings' drug delivery technology for the development of mRNA-based cancer therapeutics SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement onThursday, April 20th, f...
Samyang Holdings Biopharmaceuticals Division's Croquis Proves Efficacy and Safety in Global Webinar
* Participated in 'IMCAS Academy' webinar hosted by the IMCAS for 3 consecutive years * Brazilian dermatologists announced the superiority of Croquis, actively targeting the Latin American market * Pre-registered and recorded the most significant number of simultaneous viewers with a sin...
Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market
- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by specialist - Continued to develop evidence-based marketing to Asian markets SEOUL, South Korea, Oct. 31, 2022 /PRNewswire/ -- Samyang Holdings ...
